Exploring the synergy between tumor microenvironment modulation and STING agonists in cancer immunotherapy
Saved in:
| Main Authors: | Xiaoyan Qi, Cheng Cheng, Dawei Zhang, Zongjiang Yu, Xiangwei Meng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1488345/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profile of STING agonist and inhibitor research: a bibliometric analysis
by: Xuemei Wang, et al.
Published: (2025-02-01) -
A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists
by: Yu‐an Li, et al.
Published: (2025-01-01) -
Discovery of a non‐nucleotide stimulator of interferon genes (STING) agonist with systemic antitumor effect
by: Xiyuan Wang, et al.
Published: (2025-01-01) -
Potential therapeutic strategies for colitis and colon cancer: bidirectional targeting STING pathway
by: Jiaorong Qu, et al.
Published: (2025-01-01) -
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer
by: Nan Niu, et al.
Published: (2025-01-01)